Because most herbal products are considered dietary supplements rather than medicines, they are not required to meet standards specified in the Federal Food, Drug, and Cosmetic Act. The manufacturer of an herbal or dietary supplement can market the product as long as there is no claim of effectiveness for the prevention and treatment of a specific disease. In Australia, France, Germany, and Sweden strategies have been put in place for licensing herbal remedies.
Reportedly, 75% of the world’s population uses herbal remedies. More than 25% of individuals in most countries develop cardiovascular disease. Therefore, the potential value of herbal medicines and dietary supplements to assist with the management of cardiovascular disease, their adverse effects, and interactions with prescribed cardiovas¬cular medicines must be carefully defined.

Страницы: 1 | 2